Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, +208

The Lancet

UrologySurgical OncologyGastrointestinal OncologyMedicineBiliary Cancer +3

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100

Bruno Nervi, Pablo Ramírez, Michael P. Rettig, +8

Blood

Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial

María Elvira Balcells, Luis Rojas, Nicole Le Corre, +29

PLoS Medicine

AMD3100: CXCR4 Antagonist and Rapid Stem Cell-Mobilizing Agent

Amanda F. Cashen, Bruno Nervi, John F. DiPersio

Future Oncology

Cell TherapyImmunologyImmunotherapyRegenerative MedicineStem Cell Mobilization +15

Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis

Zachary J. Ward, Magdalena Walbaum, Benjamín Walbaum, +4

The Lancet Oncology

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID β2mnull mice

Bruno Nervi, Michael P. Rettig, Julie Ritchey, +9

Experimental Hematology

Cell TherapyTransplantationXenotransplantationMedicineStem Cell Transplantation +9

Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: A case report with a long term follow-up

Felipe Salech, Valderrama Sebastián, Bruno Nervi, +11

Annals of Hepatology

Hepatic Epithelioid HemangioendotheliomaPathologySurgeryLong Term Follow-upOncology +17

The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells

Patricia Macanas-Pirard, Thomas Quezada, Leonardo Navarrete, +4

PLoS ONE

Hematological MalignancyCcl2 ProductionMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia +10

Hippo-YAP1 Is a Prognosis Marker and Potentially Targetable Pathway in Advanced Gallbladder Cancer

Patricia García, Lorena Rosa, Sergio L. Vargas, +15

Cancers

Tumor BiologySignaling PathwayMedicinePathologyCancer Cell Biology +12

Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome

Patricia Macanas-Pirard, Richard Broekhuizen, Alfonso González, +8

Oncotarget